📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bbmt.2018.09.001

PubMed Identifier: 30205231

Publication URI: http://europepmc.org/abstract/MED/30205231

Type: Journal Article/Review

Volume: 25

Parent Publication: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Issue: 2

ISSN: 1083-8791